Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Apr;35(4):455–460. doi: 10.1136/gut.35.4.455

Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.

E Verdu 1, F Viani 1, D Armstrong 1, R Fraser 1, H H Siegrist 1, B Pignatelli 1, J P Idström 1, C Cederberg 1, A L Blum 1, M Fried 1
PMCID: PMC1374790  PMID: 8174980

Abstract

Previous studies have suggested that profound inhibition of gastric acid secretion may increase exposure to potentially carcinogenic N-nitroso compounds. The aim of this study was to find out if the proton pump inhibitor omeprazole (20 mg daily) is associated with increased concentrations of potentially carcinogenic N-nitroso compounds in gastric juice. The volume of gastric contents, number of bacteria, and concentrations of nitrates, nitrites, and N-nitroso compounds was determined in gastric aspirates obtained after an overnight fast in 14 healthy volunteers (7M:7F) after one week of treatment with placebo, and one and two weeks' treatment with omeprazole. Median bacterial concentrations were 1.0 x 10(4) (range 5.0 x 10(3)-5.0 x 10(6)) colony forming units (CFU)/ml after one weeks' treatment with placebo and increased significantly to 4.0 x 10(5) (0-3.3 x 10(7)) CFU/ml after two weeks' treatment with omeprazole (p < 0.05). A similar increase was seen in the concentration of nitrate reducing bacteria. There was no difference in the volume of gastric aspirates after treatment with omeprazole when compared with placebo (65 (29-155) ml v 42 (19-194) ml). The concentration of N-nitroso compounds was 0.13 (0-1.0) mumol/l after two weeks of omeprazole, which was not significantly different from that seen with placebo (0.15 (0-0.61) mumol/l). There was also no increase in the concentrations of nitrates or nitrites. It is concluded that omeprazole (20 mg once daily) for two weeks in healthy volunteers is associated with gastric bacterial proliferation but does not increase concentrations of N-nitroso compounds.

Full text

PDF
455

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardhan P. K., Gyr K., Beglinger C., Vögtlin J., Frey R., Vischer W. Diagnosis of bacterial overgrowth after culturing proximal small-bowel aspirate obtained during routine upper gastrointestinal endoscopy. Scand J Gastroenterol. 1992;27(3):253–256. doi: 10.3109/00365529208999959. [DOI] [PubMed] [Google Scholar]
  2. Brunner G., Creutzfeldt W. Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine. Scand J Gastroenterol Suppl. 1989;166:101–113. doi: 10.3109/00365528909091254. [DOI] [PubMed] [Google Scholar]
  3. Calmels S., Ohshima H., Vincent P., Gounot A. M., Bartsch H. Screening of microorganisms for nitrosation catalysis at pH 7 and kinetic studies on nitrosamine formation from secondary amines by E. coli strains. Carcinogenesis. 1985 Jun;6(6):911–915. doi: 10.1093/carcin/6.6.911. [DOI] [PubMed] [Google Scholar]
  4. Caygill C. P., Hill M. J., Hall C. N., Kirkham J. S., Northfield T. C. Increased risk of cancer at multiple sites after gastric surgery for peptic ulcer. Gut. 1987 Aug;28(8):924–928. doi: 10.1136/gut.28.8.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Colin-Jones D. G. Acid suppression: how much is needed? BMJ. 1990 Sep 22;301(6752):564–565. doi: 10.1136/bmj.301.6752.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gray J. D., Shiner M. Influence of gastric pH on gastric and jejunal flora. Gut. 1967 Dec;8(6):574–581. doi: 10.1136/gut.8.6.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982 Oct;126(1):131–138. doi: 10.1016/0003-2697(82)90118-x. [DOI] [PubMed] [Google Scholar]
  8. Hall C. N., Darkin D., Brimblecombe R., Cook A. J., Kirkham J. S., Northfield T. C. Evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions. Gut. 1986 May;27(5):491–498. doi: 10.1136/gut.27.5.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hetzel D. J., Dent J., Reed W. D., Narielvala F. M., Mackinnon M., McCarthy J. H., Mitchell B., Beveridge B. R., Laurence B. H., Gibson G. G. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology. 1988 Oct;95(4):903–912. doi: 10.1016/0016-5085(88)90162-x. [DOI] [PubMed] [Google Scholar]
  10. Husebye E., Skar V., Høverstad T., Melby K. Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut. 1992 Oct;33(10):1331–1337. doi: 10.1136/gut.33.10.1331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Klinkenberg-Knol E. C., Jansen J. B., Lamers C. B., Nelis F., Snel P., Meuwissen S. G. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists. Scand J Gastroenterol Suppl. 1989;166:88–94. doi: 10.3109/00365528909091251. [DOI] [PubMed] [Google Scholar]
  12. Koop H., Arnold R. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis. Dig Dis Sci. 1991 May;36(5):552–557. doi: 10.1007/BF01297018. [DOI] [PubMed] [Google Scholar]
  13. Leach S. A., Thompson M., Hill M. Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach. Carcinogenesis. 1987 Dec;8(12):1907–1912. doi: 10.1093/carcin/8.12.1907. [DOI] [PubMed] [Google Scholar]
  14. Lijinsky W. Nitrosamines and nitrosamides in the etiology of gastrointestinal cancer. Cancer. 1977 Nov;40(5 Suppl):2446–2449. doi: 10.1002/1097-0142(197711)40:5+<2446::aid-cncr2820400909>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  15. Lundell L. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Digestion. 1990;47 (Suppl 1):72–75. doi: 10.1159/000200522. [DOI] [PubMed] [Google Scholar]
  16. Milton-Thompson G. J., Lightfoot N. F., Ahmet Z., Hunt R. H., Barnard J., Bavin P. M., Brimblecombe R. W., Darkin D. W., Moore P. J., Viney N. Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment. Lancet. 1982 May 15;1(8281):1091–1095. doi: 10.1016/s0140-6736(82)92277-2. [DOI] [PubMed] [Google Scholar]
  17. Northfield T. C., Hall C. N. Carcinoma of the gastric stump: risks and pathogenesis. Gut. 1990 Nov;31(11):1217–1219. doi: 10.1136/gut.31.11.1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pignatelli B., Richard I., Bourgade M. C., Bartsch H. Improved group determination of total N-nitroso compounds in human gastric juice by chemical denitrosation and thermal energy analysis. Analyst. 1987 Jul;112(7):945–949. doi: 10.1039/an9871200945. [DOI] [PubMed] [Google Scholar]
  20. Rauws E. A. Detecting Campylobacter pylori with the 13C- and 14C-urea breath test. Scand J Gastroenterol Suppl. 1989;160:25–26. [PubMed] [Google Scholar]
  21. Reed P. I., Smith P. L., Haines K., House F. R., Walters C. L. Effect of cimetidine on gastric juice N-nitrosamine concentration. Lancet. 1981 Sep 12;2(8246):553–556. doi: 10.1016/s0140-6736(81)90940-5. [DOI] [PubMed] [Google Scholar]
  22. Reed P. I., Smith P. L., Haines K., House F. R., Walters C. L. Gastric juice N-nitrosamines in health and gastroduodenal disease. Lancet. 1981 Sep 12;2(8246):550–552. doi: 10.1016/s0140-6736(81)90939-9. [DOI] [PubMed] [Google Scholar]
  23. Ross A. H., Smith M. A., Anderson J. R., Small W. P. Late mortality after surgery for peptic ulcer. N Engl J Med. 1982 Aug 26;307(9):519–522. doi: 10.1056/NEJM198208263070902. [DOI] [PubMed] [Google Scholar]
  24. Ruddell W. S., Axon A. T., Findlay J. M., Bartholomew B. A., Hill M. J. Effect of cimetidine on the gastric bacterial flora. Lancet. 1980 Mar 29;1(8170):672–674. [PubMed] [Google Scholar]
  25. Sharma B. K., Santana I. A., Wood E. C., Walt R. P., Pereira M., Noone P., Smith P. L., Walters C. L., Pounder R. E. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) 1984 Sep 22;289(6447):717–719. doi: 10.1136/bmj.289.6447.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sharma B. K., Walt R. P., Pounder R. E., Gomes M. D., Wood E. C., Logan L. H. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut. 1984 Sep;25(9):957–964. doi: 10.1136/gut.25.9.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Snepar R., Poporad G. A., Romano J. M., Kobasa W. D., Kaye D. Effect of cimetidine and antacid on gastric microbial flora. Infect Immun. 1982 May;36(2):518–524. doi: 10.1128/iai.36.2.518-524.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tannenbaum S. R. N-nitroso compounds: a perspective on human exposure. Lancet. 1983 Mar 19;1(8325):629–632. doi: 10.1016/s0140-6736(83)91801-9. [DOI] [PubMed] [Google Scholar]
  29. Thomas J. M., Misiewicz J. J., Cook A. R., Hill M. J., Smith P. L., Walters C. L., Forster J. K., Martin L. E., Woodings D. F. Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents. Gut. 1987 Jun;28(6):726–738. doi: 10.1136/gut.28.6.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Viste A., Bjørnestad E., Opheim P., Skarstein A., Thunold J., Hartveit F., Eide G. E., Eide T. J., Søreide O. Risk of carcinoma following gastric operations for benign disease. A historical cohort study of 3470 patients. Lancet. 1986 Aug 30;2(8505):502–505. doi: 10.1016/s0140-6736(86)90368-5. [DOI] [PubMed] [Google Scholar]
  31. Watt P. C., Patterson C. C., Kennedy T. L. Late mortality after vagotomy and drainage for duodenal ulcer. Br Med J (Clin Res Ed) 1984 May 5;288(6427):1335–1338. doi: 10.1136/bmj.288.6427.1335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Watt P. C., Sloan J. M., Donaldson J. D., Patterson C. C., Kennedy T. L. Relationship between histology and gastric juice pH and nitrite in the stomach after operation for duodenal ulcer. Gut. 1984 Mar;25(3):246–252. doi: 10.1136/gut.25.3.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wormsley K. G. Assessing the safety of drugs for the long-term treatment of peptic ulcers. Gut. 1984 Dec;25(12):1416–1423. doi: 10.1136/gut.25.12.1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. du Moulin G. C., Paterson D. G., Hedley-Whyte J., Lisbon A. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet. 1982 Jan 30;1(8266):242–245. doi: 10.1016/s0140-6736(82)90974-6. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES